Viral Shedding Duration of Pandemic Influenza A H1N1 Virus during an Elementary School Outbreak-Pennsylvania, May-June 2009

被引:25
作者
Bhattarai, Achuyt [1 ]
Villanueva, Julie [1 ,2 ]
Palekar, Rakhee S. [1 ]
Fagan, Ryan [1 ]
Sessions, Wendy [1 ]
Winter, Joern [1 ]
Berman, LaShondra [1 ]
Lute, James [3 ]
Leap, Rebecca [1 ]
Marchbanks, Tiffany [3 ]
Sodha, Samir V. [1 ]
Moll, Maria [3 ]
Xu, Xiyan [1 ]
Fry, Alicia [1 ]
Fiore, Anthony [1 ]
Ostroff, Stephen [3 ]
Swerdlow, David L. [1 ]
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA USA
[2] Battelle Mem Inst, Atlanta, GA USA
[3] Penn Dept Hlth, Harrisburg, PA 17108 USA
关键词
INFECTION;
D O I
10.1093/cid/ciq026
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report shedding duration of 2009 pandemic influenza A (pH1N1) virus from a school-associated outbreak in Pennsylvania during May through June 2009. Outbreak-associated students or household contacts with influenza-like illness (ILI) onset within 7 days of interview were recruited. Nasopharyngeal specimens, collected every 48 hours until 2 consecutive nonpositive tests, underwent real-time reverse transcriptase polymerase chain reaction (rRT-PCR) and culture for pH1N1 virus. Culture-positive specimens underwent virus titrations. Twenty-six (median age, 8 years) rRT-PCR-positive persons, for pH1N1 virus, were included in analysis. Median shedding duration from fever onset by rRT-PCR was 6 days (range, 1-13) and 5 days (range, 1-7) by culture. Following fever resolution virus was isolated for a median of 2 days (range, 0-5). Highest and lowest virus titers detected, 2 and 5 days following fever onset, were 3.2 and 1.2 log(10) TCID(50)/mL respectively. Overall, shedding duration in children and adults were similar to seasonal influenza viruses.
引用
收藏
页码:S102 / S108
页数:7
相关论文
共 15 条
[1]   Influenza virus shedding-Excretion patterns and effects of antiviral treatment [J].
Aoki, Fred Y. ;
Boivin, Guy .
JOURNAL OF CLINICAL VIROLOGY, 2009, 44 (04) :255-261
[2]  
Bell D, 2006, EMERG INFECT DIS, V12, P81
[3]   Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection [J].
Calfee, DP ;
Peng, AW ;
Cass, LM ;
Lobo, M ;
Hayden, FG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1616-1620
[4]   Time lines of infection and disease in human influenza: A review of volunteer challenge studies [J].
Carrat, Fabrice ;
Vergu, Elisabeta ;
Ferguson, Neil M. ;
Lemaitre, Magali ;
Cauchemez, Simon ;
Leach, Steve ;
Valleron, Alain-Jacques .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (07) :775-785
[5]  
*CDC, CDC GUID STAT LOC PU
[6]  
*CDC, CDC REC AM TIM PERS
[7]  
*CDC, EM US AUTH RRT PCR S
[8]   Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team [J].
Dawood, Fatimah S. ;
Jain, Seema ;
Finelli, Lyn ;
Shaw, Michael W. ;
Lindstrom, Stephen ;
Garten, Rebecca J. ;
Gubareva, Larisa V. ;
Xu, Xiyan ;
Bridges, Carolyn B. ;
Uyeki, Timothy M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (25) :2605-2615
[9]   Local and systemic cytokine responses during experimental human influenza A virus infection - Relation to symptom formation and host defense [J].
Hayden, FG ;
Fritz, RS ;
Lobo, MC ;
Alvord, WG ;
Strober, W ;
Straus, SE .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (03) :643-649
[10]  
REED L. J., 1938, AMER JOUR HYG, V27, P493